Luminex Corporation (LMNX) Tops Q1 EPS by 5c, Revenue Beats Expectations
Tweet
Share
E-mailGet Alerts LMNX Hot Sheet
Price: $9.05 +5.23%
Financial Fact:
Income from operations: 4.03M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income from operations: 4.03M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Luminex Corporation (NASDAQ: LMNX) reported Q1 EPS of $0.11, $0.05 better than the analyst estimate of $0.06. Revenue for the quarter came in at $43.3 million versus the consensus estimate of $39.9 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
